Staidson (Beijing) BioPharmaceuticals Co., Ltd.

¥17.55As of Sun 8 Nov 2026, 12:00 UTC
SZSE:300204Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (7.41%)
Biotechnology
Beta (5Y) 0.73
PE TTM —
TSR TTM (54.18%)
Mkt cap ¥9.501B
ROIC (10.44%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥22
27.70%
2.42%
Hold 1|1|11|0|9
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.20
0.20
0.21
0.20
4.45%
8.17%
13.73%
2.95%
Revenue¥B
1.108
1.120
1.158
1.177
8.85%
10.99%
12.42%
9.66%
Peers (US$1.424B)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
2.470
0.583
0.555
EBIT/Intx
0.060
0.042
0.052
Own earn%
274.99
(229.41)
(174.08)
Sh yield%
15.29
14.31
17.86
Owners
Insiders/Inst%
14.20
36.93
Short interest%
3.81
SBC / revenue%
1.19
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
13–24
$1 testx
—
Incr. ROIC%
3